Eva Jack is the founder of HotSpot Therapeutics. HotSpot Therapeutics has raised $210M in total funding. Latest round: Series C. Backed by Atlas Venture.
Eva Jack is the Chief Operating Officer at HotSpot Therapeutics, a biotechnology company focused on discovering and developing first-in-class allosteric therapies. Prior to joining HotSpot, she served as Chief Business Officer at Mersana Therapeutics, where she helped transition the company from an early-stage startup to a publicly traded, clinical-stage organization. Her background also includes leadership roles at Macava Consulting, Pulmatrix, MedImmune (where she was Managing Director of MedImmune Ventures), and Intel Corp.
Full founder directory · Investor directory · Company funding database · Fundraising library